'Drug market' presentation slideshows

Spatial Clustering of Illegal Drug Dealers: Swarming for Safety or Agglomeration for Profit

Spatial Clustering of Illegal Drug Dealers: Swarming for Safety or Agglomeration for Profit Dr. George F. Rengert Department of Criminal Justice Temple University Philadelphia, PA. 19122 grengert@temple.edu. Where can illegal drug markets locate? Folk wisdom: any where they want to.

613 views • 61 slides

Legal Highs- What is it all about?

285 views • 27 slides

Political Determinants of Violence in the Metropolitan Area of Buenos Aires

361 views • 25 slides

793 views • 19 slides

Problems with New Psychoactive Substances and how to deal with it

323 views • 18 slides

Novel Drug Marketing

Novel Drug Marketing. Group 2 Mahinda C. Edirisooriya. Content. Hepatocelluar Carcinoma (HCC) HCC distribution & Incidence Development of novel drug Novel drug company Drug regulation and distribution

363 views • 17 slides

Novel Drug Marketing

Novel Drug Marketing. Group 2 Mahinda C. Edirisooriya. Content. Hepatocelluar Carcinoma (HCC) HCC distribution & Incidence Development of novel drug Novel drug company Drug regulation and distribution

176 views • 17 slides

225 views • 13 slides

Japan Generic Drug Market Size to Expand at a CAGR of 10% during 2019-2024

Get more information about the market: https://www.imarcgroup.com/japan-generic-drug-market The Japan generic drug market reached a value of US$ 13.4 Billion in 2018, growing at a CAGR of nearly 9% during 2011-2018. Looking forward, the market is projected to reach a value of US$ 23.5 Billion by 2024, exhibiting a CAGR of around 10% during the next five years. Want more information about this market? Request a free report sample: https://www.imarcgroup.com/japan-generic-drug-market/requestsample For India market research reports, visit: http://www.marketresearchindia.co.in Browse Related Report Generic Drug Market Report: https://www.imarcgroup.com/generic-drug-manufacturing-plant HIV Drug Market Report: https://www.imarcgroup.com/hiv-drug-market Contact Us IMARC Group James Smith Email: Sales@imarcgroup.com Tel No:(D) 91 120 433 0800 | https://www.imarcgroup.com Americas :- 1 631 791 1145 | Africa and Europe :- 44-702-409-7331 Linkedin: https://www.linkedin.com/company/imarc-group

109 views • 10 slides

Hepatitis C Drugs Market - Global Industry 2025

Hepatitis C virus is a blood-borne virus that infects liver cells, resulting in illness that ranges from mild and transient effects such as easy bleeding, fatigue, yellow discoloration of skin and eyes, and others to chronic and serious life-threatening conditions such as liver cirrhosis, liver cancer or liver failure. Hepatitis C virus is transmitted through needlestick injuries, organ transplant from a carrier, sexually or from infected mother to fetus.

108 views • 9 slides

Atopic Dermatitis Drug Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

Atopic dermatitis, also known as eczema, is a condition in which skin becomes dry, itchy, and inflamed, which leads to redness, swelling, scaling, and crusting. Atopic dermatitis is commonly found in children under one year. The exact cause of atopic dermatitis is undiscovered, but it is believed that it includes genetics, environmental exposure, immune system dysfunction, and problem with skin permeability. Dry climate is also a major cause of atopic dermatitis. This disease is non-contagious and easily diagnosed with signs and symptoms such as swelling and redness of skin. Many people with atopic dermatitis develop asthma and hay fever. Atopic dermatitis treatment involves photo therapy, steroid pills, calcineurin inhibitors ointment, biologic agents such as immunologic, monoclonal antibody, and dietary changes in case of food allergy.

118 views • 8 slides

Global Drug Screening Market – Industry Trends and Forecast to 2024

Global Drug Screening Market By Products and Services (Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents), Sample Type (Urine, Breath, Saliva, Hair, Blood, Skin, Sweat)Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

88 views • 7 slides

Latest Guidebook for Conducting Pharma Clinical Trials in China: From Regulations to Practice

China is one of the fastest growing global economies with a fifth population in the world, and is one of the largest healthcare markets around the world. Along with sustained economic and population growth as well as an ageing population, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. By 2013, total value of drugs on Chinese healthcare market has reached RMB 1114 billion. On the Chinese healthcare market, imported drugs made by overseas and multinational pharmaceutical manufacturers account for about one fourth. It is estimated that total value of drugs on Chinese healthcare market will be likely to be more than RMB 1450 billion by 2015, and will surpass Japan to become the second largest drug market following the United States. The Chinese healthcare market will attract more and more overseas pharmaceutical manufacturers and producers to penetrate such market. Many overseas and multinational pharmaceutical manufacturers are ardently conducting clinical trials for their drugs in China to seize a larger part of such drug market. However, the Chinese approach to GCP compliance is unique, from the application and approval process, the requirements for ethics committees, sponsors and investigators to the application dossiers. To enter such a lucrative drug market, overseas and multinational pharmaceutical manufacturers and producers must have a comprehensive and thorough knowledge of the latest Chinese regulations on clinical trials. Otherwise, the restrictive legal requirements and approval delays eat up your development time and budget.

217 views • 6 slides

Cardiovascular Diseases Market

With the increasing prevalence of cardiovascular disease, the drug market for cardiovascular disease will demonstrate the health growth rate. The rising aging population, diabetic patients, obese and leaving habits will boost the market for the cardiovascular disease. Visit us: https://www.scalarmarketresearch.com/market-reports/cardiovascular-diseases-market

215 views • 6 slides

Drug Master File

How to register Drug Master File in USA

256 views • 3 slides

Vial Adaptors for Reconstitution Drug Market Research Report Forecast to 2024

According to the research report, the global vial adaptors for reconstitution drug market was valued at US$780 million in 2015 and is expected to reach US$1.3 billion by the end of 2024. Between the forecast years of 2016 and 2024, the global market is expected to progress at a CAGR of 7.5%.

44 views • 3 slides

Vial Adaptors for Reconstitution Drug Market Research Report Forecast to 2024

According to the research report, the global vial adaptors for reconstitution drug market was valued at US$780 million in 2015 and is expected to reach US$1.3 billion by the end of 2024. Between the forecast years of 2016 and 2024, the global market is expected to progress at a CAGR of 7.5%.

40 views • 3 slides

Growing prevalence rates of Alzheimeru2019s disease globally and rising geriatric population worldwide is anticipated to fuel the growth of Alzheimeru2019s drugs market.

34 views • 3 slides

A new market study on the global Bacterial Vaginosis Drug market has been recently added to the repository of eonmarketresearch.com. The research study, titled u201cGlobal Bacterial Vaginosis Drug Market Research Report 2019,u201d evaluates the historical performance and the current status of this market for a detailed understanding, emphasizing especially on the dynamics of the demand and supply of Bacterial Vaginosis Drug in 2018.

34 views • 3 slides